Ellington Financial Valuation
Is 0A26 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0A26 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0A26 ($12.36) is trading below our estimate of fair value ($16.87)
Significantly Below Fair Value: 0A26 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0A26?
Key metric: As 0A26 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 0A26's PE Ratio? | |
|---|---|
| PE Ratio | 10.5x |
| Earnings | US$107.93m |
| Market Cap | US$1.13b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does 0A26's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 11.6x | ||
ALPH Alpha Group International | 10x | 6.3% | UK£937.0m |
PAY PayPoint | 14.5x | n/a | UK£582.5m |
XPS XPS Pensions Group | 12.5x | -14.5% | UK£771.0m |
BPCR BioPharma Credit | 9.6x | n/a | US$1.1b |
0A26 Ellington Financial | 10.5x | 15.2% | US$1.1b |
Price-To-Earnings vs Peers: 0A26 is good value based on its Price-To-Earnings Ratio (10.5x) compared to the peer average (11.5x).
Price to Earnings Ratio vs Industry
How does 0A26's PE Ratio compare vs other companies in the Global Mortgage REITs Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 0A26 is good value based on its Price-To-Earnings Ratio (10.5x) compared to the Global Mortgage REITs industry average (10.6x).
Price to Earnings Ratio vs Fair Ratio
What is 0A26's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10.5x |
| Fair PE Ratio | 16.1x |
Price-To-Earnings vs Fair Ratio: 0A26 is good value based on its Price-To-Earnings Ratio (10.5x) compared to the estimated Fair Price-To-Earnings Ratio (16.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$12.36 | US$13.75 +11.2% | 4.2% | US$14.50 | US$12.50 | n/a | 7 |
| Nov ’25 | US$12.00 | US$13.75 +14.6% | 4.2% | US$14.50 | US$12.50 | n/a | 7 |
| Oct ’25 | US$12.59 | US$13.61 +8.1% | 4.6% | US$14.50 | US$12.50 | n/a | 7 |
| Sep ’25 | US$13.03 | US$13.50 +3.6% | 4.8% | US$14.50 | US$12.50 | n/a | 7 |
| Aug ’25 | US$12.58 | US$13.43 +6.8% | 5.8% | US$14.50 | US$12.00 | n/a | 7 |
| Jul ’25 | US$11.78 | US$13.50 +14.6% | 6.3% | US$14.50 | US$12.00 | n/a | 7 |
| Jun ’25 | US$12.11 | US$13.50 +11.5% | 6.3% | US$14.50 | US$12.00 | n/a | 7 |
| May ’25 | US$11.57 | US$13.54 +17.0% | 6.1% | US$14.50 | US$12.00 | n/a | 7 |
| Apr ’25 | US$11.75 | US$13.89 +18.3% | 6.9% | US$15.50 | US$12.50 | n/a | 7 |
| Mar ’25 | US$11.38 | US$14.18 +24.6% | 6.2% | US$15.50 | US$13.00 | n/a | 7 |
| Feb ’25 | US$12.37 | US$14.57 +17.8% | 5.0% | US$15.50 | US$13.50 | n/a | 7 |
| Jan ’25 | US$12.71 | US$14.57 +14.7% | 5.0% | US$15.50 | US$13.50 | n/a | 7 |
| Dec ’24 | US$13.14 | US$14.75 +12.3% | 4.3% | US$15.50 | US$14.00 | n/a | 6 |
| Nov ’24 | US$12.23 | US$14.75 +20.6% | 4.3% | US$15.50 | US$14.00 | US$12.00 | 6 |
| Oct ’24 | US$12.53 | US$14.43 +15.2% | 6.3% | US$15.50 | US$13.00 | US$12.59 | 7 |
| Sep ’24 | US$13.40 | US$14.38 +7.3% | 6.0% | US$15.50 | US$13.00 | US$13.03 | 8 |
| Aug ’24 | US$13.60 | US$14.34 +5.5% | 6.1% | US$15.50 | US$13.00 | US$12.58 | 8 |
| Jul ’24 | US$13.91 | US$14.09 +1.4% | 6.1% | US$15.50 | US$13.00 | US$11.78 | 8 |
| Jun ’24 | US$12.60 | US$14.09 +11.9% | 6.1% | US$15.50 | US$13.00 | US$12.11 | 8 |
| May ’24 | US$12.75 | US$14.28 +12.0% | 5.1% | US$15.50 | US$13.50 | US$11.57 | 8 |
| Apr ’24 | US$12.22 | US$14.66 +20.0% | 5.0% | US$15.50 | US$13.75 | US$11.75 | 8 |
| Mar ’24 | US$12.71 | US$14.66 +15.3% | 5.0% | US$15.50 | US$13.75 | US$11.38 | 8 |
| Feb ’24 | US$13.88 | US$14.59 +5.2% | 4.7% | US$15.50 | US$13.75 | US$12.37 | 8 |
| Jan ’24 | US$12.42 | US$15.03 +21.0% | 7.0% | US$17.00 | US$13.75 | US$12.71 | 8 |
| Dec ’23 | US$13.86 | US$15.03 +8.4% | 7.0% | US$17.00 | US$13.75 | US$13.14 | 8 |
| Nov ’23 | US$13.13 | US$15.16 +15.4% | 6.4% | US$17.00 | US$13.75 | US$12.23 | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
BFF Bank
€1.7b
Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.
0RON
€9.05
7D
2.6%
1Y
-9.2%
HAL Trust
€10.4b
Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.
0K9V
€116.20
7D
1.8%
1Y
2.7%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.11
7D
0.1%
1Y
-2.5%